9% Solución para perfusión Cloruro de sodio

DRUG3 trials

Sponsors

Odense University Hospital, European Foundation For The Study Of Chronic Liver Failure, Hospital General Universitario Dr. Balmis

Conditions

Acute pancreatitisLiver cirrhosis

Phase 3

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

WithdrawnCTIS2022-501006-34-00

Odense University Hospital, European Foundation For The Study Of Chronic Liver FailureLiver cirrhosis

Target: 180Updated: 2022-10-05

ALB-TRIAL: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites

RecruitingCTIS2022-501006-34-01

Odense University Hospital, European Foundation For The Study Of Chronic Liver FailureLiver cirrhosis

Start: 2023-03-29Target: 210Updated: 2025-10-07

Phase 4

Normal saline versus lactated Ringer’s solution for acute pancreatitis resuscitation, an open-label multicenter randomized controlled trial: the WATERLAND trial

CompletedCTIS2023-509879-16-00

Hospital General Universitario Dr. BalmisAcute pancreatitis

End: 2024-08-30Target: 100Updated: 2024-05-17

Related Papers

Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial

BMJ Open2024-02-018 citations